Impact of Intraoperative Oxygenation Practices on Patient Outcomes
Sponsor: Frederic T Billings IV • ClinicalTrials.gov ID: NCT07224243
Recruiting for Similar Conditions?
Sponsors are looking for patients like you. See if you qualify for compensated research studies.
Check Eligibility →Description
This multicenter, cluster-randomized, cluster-crossover clinical trial evaluates the impact of three intraoperative FiO2 (Fraction of Inspired Oxygen) oxygenation strategies-lower (FiO₂ 0.21-0.40), intermediate (FiO₂ 0.40-0.80), and higher (FiO₂ 0.80-1.00)-on postoperative organ injury and mortality in adult surgical patients. The trial aims to determine the optimal oxygenation strategy to improve perioperative outcomes.
Interventions
-
Lower FiO2
(Other)
FiO₂ 0.21-0.40 or lowest FiO₂ to maintain SpO₂ ≥ 94% during maintenance anesthesia
-
Intermediate FiO2
(Other)
FiO₂ 0.40-0.80 or lowest FiO₂ to maintain SpO₂ ≥ 94% during maintenance anesthesia
-
Higher FiO2
(Other)
FiO₂ \> 0.80 to maintain SpO₂ ≥ 94% during maintenance anesthesia
Eligibility criteria
Conditions
Locations
- University of Michigan Hospital — Ann Arbor, Michigan, United States
- Nebraska Medical Center — Omaha, Nebraska, United States
- Vanderbilt University Medical Center — Nashville, Tennessee, United States
- University of Utah Huntsman Cancer Institute — Salt Lake City, Utah, United States
Partner with Nurenyx
Showcase your study to thousands of motivated patients matching your criteria.
Learn MoreOfficial Source
Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
View Official Record